Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Oncogene|December 4, 2021
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AMLLuciano Nicosia, Francesca Ludovica Boffo, Elena Ceccacci, et al.Bioorganic & Medicinal Chemistry Letters|May 27, 2017
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1Daniel P Mould, Ulf Bremberg, Allan M Jordan, et al.Iscience|August 4, 2023
Differentiation block in acute myeloid leukemia regulated by intronic sequences of FTOFrancesco Camera, Isabel Romero-Camarero, Bradley H Revell, et al.Plos One|May 30, 2023
Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patientsStella Pearson, Rognvald Blance, Fei Yan, et al.Cancer Cell|September 17, 2015
Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid LeukemiaTim D D Somerville, Daniel H Wiseman, Gary J Spencer, et al.Scientific Reports|March 22, 2019
Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesisChiou-Hong Lin, Zhong Wang, Jesús Duque-Afonso, et al.Cell Reports|January 19, 2018
Derepression of the Iroquois Homeodomain Transcription Factor Gene IRX3 Confers Differentiation Block in Acute LeukemiaTim D D Somerville, Fabrizio Simeoni, John A Chadwick, et al.Leukemia|November 30, 2019
Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemiaGauri Deb, Bettina Wingelhofer, Fabio M R Amaral, et al.BMC Cancer|November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancerMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.Iscience|August 22, 2024
Conserved role of FOXC1 in TNBC is parallel to FOXA1 in ER+ breast cancerRevathy Ramachandran, Shakhzada Ibragimova, Laura M Woods, et al.Pageof 8